Get Started

GNTA

NASD Genenta Science SpA Sponsored ADR
Nov 4, 2026 · 9:47 AM ET EOD Market Open

$0.9850 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.9850, $0.0050 below the day’s high of $0.9900

YTD change
-33.89%
vs 20-day SMA
+44.92%
vs 200-day SMA
-4.85%

Price ranges

Previous day
$0.8189 $0.9900
open $0.8359 close $0.9850
+$0.1491 (+17.84%)
Today
$0.8189 $0.9900
open $0.8359 now $0.9850
+$0.1491 (+17.84%)
Past week
$0.5801 $0.8700
from $0.6244 now $0.9850
+$0.3606 (+57.75%)
Past month
$0.5801 $0.8700
from $0.7300 now $0.9850
+$0.2550 (+34.93%)
This year
$0.5500 $2.5800
from $1.4900 now $0.9850
-$0.5050 (-33.89%)

Price & Performance

+0.29 (+42.32%) / 6M

$0.4504$1.08$1.70$2.33May 4Aug 4Nov 3

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 92.5% away from all-time highs of $13.1300
  • GNTA is down 34% since the beginning of the year
  • GNTA is down 62% over the past 12 months
  • GNTA is up 35% over the past 1 month
  • 0% of all GNTA investors are betting against GNTA

GNTA reads very good: price sits above one of the two key moving averages, the 12-month move is -57.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $-8035130.0
Beta 0.61

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$33.1M
Debt$8.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $47.5M

Genenta Science SpA operates as a biotechnology company, which engages in strategic consolidation focused on acquiring majority or full ownership of privately held, established companies operating in Italian national security-regulated sectors. Its activities and acquisition strategy span aerospace, defense, national security, including cybersecurity, and biotechnology and biosecurity. The company was founded by Pierluigi Paracchi, Bernhard Gentner, and Luigi Naldini on July 24, 2014 and is headquartered in Milan, Italy.

Competitor comparison

TickerCompany PriceChange
ARGNF argenx SE $900.30 N/A
GNNSF Genscript Biotech Corporation $4.50 +0.00%
GLXY Galaxy Digital Inc. Class A $16.83 +15.35%
PVLA Palvella Therapeutics, Inc. $152.93 +4.51%
EPRX Eupraxia Pharmaceuticals, Inc. $6.88 +1.78%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.